@article{4f16a963dc8146b79f96bdb641c4b030,
title = "Disclose and Manage Conflicts of Interest at Cancer Centers",
author = "Jensen, {Roy A.} and Knudsen, {Karen E.} and Platanias, {Leonidas C.}",
note = "Funding Information: Author Affiliations: Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York. Corresponding Author: Frances R. Levin, MD, New York State Psychiatric Institute, 1051 Riverside Dr, Unit 66, New York, NY 10032 (frl2@columbia.edu). Conflict of Interest Disclosures: Drs Levin and Mariani report receiving research grants from the National Institutes of Health{\textquoteright}s National Institute on Drug Abuse (U54DA03784201 and U01DA045372). 1. Lintzeris N, Bhardwaj A, Mills L, et al; Agonist Replacement for Cannabis Dependence (ARCD) study group. Nabiximols for the treatment of cannabis dependence: a randomized clinical trial. JAMA Intern Med. 2019;179(9):1242-1253. doi:10.1001/jamainternmed.2019.1993 2. Lee DC, Schlienz NJ, Peters EN, et al. Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder. Drug Alcohol Depend. 2019;194:500-517. doi:10.1016/j. drugalcdep.2018.10.020 3. Haney M, Cooper ZD, Bedi G, Vosburg SK, Comer SD, Foltin RW. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse. Neuropsychopharmacology. 2013;38(8):1557-1565. doi:10.1038/npp.2013.54",
year = "2020",
month = jan,
doi = "10.1001/jamainternmed.2019.5542",
language = "English (US)",
volume = "180",
pages = "161",
journal = "Archives of internal medicine (Chicago, Ill. : 1908)",
issn = "2168-6106",
publisher = "American Medical Association",
number = "1",
}
